Skip to Content
  1. All products
  2. GLP-1 Medications
  3. Semaglutide (Wegovy)
  4. GLP-1 Medications
Pricelist: Default Pricelist
Pricelist: Default Pricelist
RX
Semaglutide (Wegovy)

Semaglutide (Wegovy)

Once-weekly GLP-1 injection for weight management. Consult your doctor for dosage.

4 doses (1 month supply)

₹ 9,982.00 ₹ 10,850.00

  • Dosage

Wegovy® contains semaglutide, a medication that activates GLP-1 (glucagon-like peptide-1) receptors. This hormone helps regulate appetite, blood sugar levels, and energy balance.

Wegovy is prescribed for chronic weight management in adults and certain adolescents with obesity or overweight, especially when weight is associated with conditions such as type 2 diabetes, high blood pressure, or high cholesterol.


How Wegovy Works

Wegovy works by mimicking the natural GLP-1 hormone in the body.

This helps the body by:

• Increasing insulin release when blood sugar levels rise

• Reducing glucose production from the liver

• Slowing stomach emptying to promote fullness

• Acting on brain appetite centers to reduce hunger and cravings

This combined action helps support sustained weight reduction and improved metabolic health.


How It’s Taken

Wegovy is administered as a once-weekly injection under the skin.

Common injection sites include:

• Abdomen

• Thigh

• Upper arm

Treatment typically begins with a low starting dose, which gradually increases over several weeks to help minimize side effects.


Potential Benefits

Wegovy may help:

• Support significant weight reduction

• Reduce appetite and food cravings

• Improve blood sugar regulation

• Improve cardiovascular and metabolic health markers


Common Side Effects

Some individuals may experience side effects, particularly during early treatment.

Common side effects include:

• Nausea

• Diarrhea

• Vomiting

• Constipation

• Abdominal pain

• Headache

• Fatigue

These symptoms are often temporary and tend to improve as the body adjusts to treatment.


Safety Information

Before starting Wegovy, inform your doctor if you have a history of:

• Pancreatitis

• Thyroid cancer

• Gallbladder disease

• Severe gastrointestinal conditions

Wegovy should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Always discuss current medications, supplements, and health conditions with your healthcare provider before starting treatment.


Missed Dose

If a dose is missed:

• Take the missed injection within 5 days of the scheduled time

• If more than 5 days have passed, skip the missed dose and take the next dose on the regularly scheduled day

Do not take two doses at the same time.


Key Facts

Drug Class: GLP-1 Receptor Agonist

Administration: Once-weekly injection

Primary Use: Chronic weight management

Habit Forming: No

Common Questions

Answered
directly.

GLP-1 medication is not prescribed universally. Every patient undergoes a thorough clinical evaluation — reviewing medical history, current conditions, and relevant investigations — before any prescription is made. The decision is always made by the doctor, not an algorithm.

Clinical data shows patients on GLP-1 therapy lose around 12–15% of body weight during treatment when combined with dietary guidance. Results vary depending on physiology, adherence, and dosage.

If suitable, your doctor creates a personalised dosing protocol. You receive a prescription, monitoring schedule, and direct access to your care team. Early treatment usually includes weekly check-ins.

GLP-1 medication works with the body's appetite signals, meaning rigid dieting often becomes unnecessary. Your doctor will provide practical nutritional guidance that complements the medication.

The most common side effects are nausea, mild fatigue, and appetite changes in the early weeks. These are managed by starting with a low dose and adjusting gradually under medical supervision.

Treatment duration varies. Some patients continue for 12–18 months, while others transition to maintenance earlier. The timeline depends on your medical progress.